FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 39 filers reported holding FORTRESS BIOTECH INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,526,558 | -47.2% | 5,258,555 | +0.1% | 0.00% | – |
Q2 2023 | $2,888,850 | -32.7% | 5,252,455 | +0.3% | 0.00% | – |
Q1 2023 | $4,292,788 | +28.4% | 5,235,107 | +2.6% | 0.00% | – |
Q4 2022 | $3,343,387 | -23.8% | 5,104,407 | -0.0% | 0.00% | – |
Q3 2022 | $4,390,000 | +1.9% | 5,104,800 | -0.5% | 0.00% | – |
Q2 2022 | $4,310,000 | -44.2% | 5,131,708 | -9.6% | 0.00% | – |
Q1 2022 | $7,718,000 | -45.7% | 5,674,538 | -0.3% | 0.00% | – |
Q4 2021 | $14,226,000 | -18.1% | 5,690,274 | +5.5% | 0.00% | – |
Q3 2021 | $17,372,000 | -9.4% | 5,395,078 | +0.4% | 0.00% | – |
Q2 2021 | $19,180,000 | +5.6% | 5,372,743 | +4.5% | 0.00% | – |
Q1 2021 | $18,156,000 | +25.4% | 5,143,508 | +12.6% | 0.00% | – |
Q4 2020 | $14,481,000 | +9.6% | 4,568,176 | +39.6% | 0.00% | – |
Q3 2020 | $13,216,000 | +119.1% | 3,271,387 | +45.3% | 0.00% | – |
Q2 2020 | $6,032,000 | +77.5% | 2,250,941 | +25.1% | 0.00% | – |
Q1 2020 | $3,399,000 | -20.3% | 1,798,888 | +8.4% | 0.00% | – |
Q4 2019 | $4,266,000 | +72.2% | 1,659,835 | -5.5% | 0.00% | – |
Q3 2019 | $2,478,000 | -21.8% | 1,757,210 | -16.8% | 0.00% | – |
Q2 2019 | $3,169,000 | +39.7% | 2,112,586 | +65.8% | 0.00% | – |
Q1 2019 | $2,268,000 | +142.8% | 1,274,072 | +17.3% | 0.00% | – |
Q4 2018 | $934,000 | -53.2% | 1,085,825 | -13.0% | 0.00% | – |
Q3 2018 | $1,997,000 | -45.1% | 1,248,040 | +2.2% | 0.00% | – |
Q2 2018 | $3,640,000 | -33.7% | 1,221,648 | +1.3% | 0.00% | – |
Q1 2018 | $5,487,000 | +11.9% | 1,205,859 | -1.9% | 0.00% | – |
Q4 2017 | $4,902,000 | -7.1% | 1,228,683 | +3.0% | 0.00% | – |
Q3 2017 | $5,274,000 | -14.0% | 1,193,273 | -7.6% | 0.00% | – |
Q2 2017 | $6,132,000 | +18.6% | 1,290,960 | -7.6% | 0.00% | – |
Q1 2017 | $5,170,000 | +44.0% | 1,397,435 | +5.1% | 0.00% | – |
Q4 2016 | $3,591,000 | -9.8% | 1,329,833 | -0.8% | 0.00% | – |
Q3 2016 | $3,982,000 | +10.0% | 1,340,656 | -0.4% | 0.00% | – |
Q2 2016 | $3,619,000 | -6.9% | 1,345,439 | +7.3% | 0.00% | – |
Q1 2016 | $3,888,000 | +11.1% | 1,254,197 | 0.0% | 0.00% | – |
Q4 2015 | $3,499,000 | -97.6% | 1,254,197 | -81.4% | 0.00% | -100.0% |
Q3 2015 | $147,385,000 | +3515.9% | 6,752,730 | +456.6% | 0.01% | – |
Q2 2015 | $4,076,000 | – | 1,213,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
Summit Global Investments | 44,900 | $145,000 | 0.01% |
Virtu Financial LLC | 25,714 | $83,000 | 0.01% |